// App-Quantinova.ai

14337 : Prospective Study of Adiponectin and Von Willebrand Factor for Clinical Outcomes After 3 Years in Non-Valvular Atrial Fibrillation

Researchers

Presenter

  • Danielle Vlazny

Principal Investigators

  • Robert D McBane

  • Rowlens M Melduni

  • Naser M Ammash

  • Ewa A Konik

  • Ana I Casanegra

  • Matylda Mazur

  • Damon Houghton

  • Josh Slusser

  • Diane Grill

  • Waldemar E Wysokinski

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

Disease

  • Non-valvular atrial fibrillation

  • Left Atrial Appendage Thrombus

  • Myocardial infarction

  • Arrhythmia

  • Venous thrombosis

  • Stroke

Biomarkers

  • Adiponectin

  • von Willebrand factor

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A